Aggressive Stem Cell Transplant Approach Halts MS for Years, But Risks are High

Autologous haematopoietic stem cell transplantation (aHSCT) has been used to stop autoimmune processes in multiple sclerosis (MS), although the treatment is not effective for every person. Now, an improved version of the technique is showing astonishingly good results, with patients free of both the need for treatment and the risk of relapses for years on end — but … Continue reading Aggressive Stem Cell Transplant Approach Halts MS for Years, But Risks are High